Viewing Study NCT05185505

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:19 AM
Ignite Modification Date: 2026-06-27 @ 12:30 PM
Study NCT ID: NCT05185505
Status: RECRUITING
Last Update Posted: 2023-02-01
First Post: 2021-12-10
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Atezolizumab and Bevacizumab Pre-Liver Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria
Sponsor: The Methodist Hospital Research Institute
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatocellular Carcinoma View
None Hepatocellular Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Bevacizumab View
None atezolizumab View
None Neoadjuvant Therapy View
None Liver Neoplasms View
None Liver Transplantation View